Reproductive Health

Rosy Expands Services to Address Women’s Health Beyond Sexual Wellness

In a strategic move to broaden its scope, Rosy, led by Dr. Lyndsey Harper, is expanding its platform beyond sexual wellness to encompass various aspects of women’s health. This expansion targets areas such as endometriosis, fibroids, menopause, migraines, and more, aiming to provide comprehensive support for women across all stages of life. Rosy’s initiative is rooted in the recognition of unmet needs…

Alife Health Partners with Boston IVF to Introduce AI Technology for IVF Treatment Optimization

Alife Health, a leading fertility technology company specializing in AI tools for in vitro fertilization (IVF), has announced a strategic partnership with Boston IVF, a prominent fertility clinic with over 25 locations across the U.S. The collaboration aims to implement the country’s first AI tool for IVF medication optimization, with the objective of enhancing patient outcomes through data-driven decisions. The collaboration between…

Womed Leaf’s Clinical Success Promises to Significantly Reduce Uterine Adhesions Boosting Fertility

French women’s health company Womed recently announced significant advancements in the treatment of intrauterine adhesions (IUAs), a major cause of female infertility, with its product, Womed Leaf. The announcement came following the successful results of the PREG2 clinical trial, which were shared by Prof. Jean-Louis Benifla during the Choix des Armes conference in Marseille, France and suggest that Womed’s technology can help…

How Hybrid Care Startup Oya Is Setting New Standards for Women’s and Reproductive Health in Brazil

Two years have passed since Oya Care announced its $3 million seed funding round, secured from Susa Ventures, with additional investment from Brazilian entities Canary, Positive, and IKJ. In that time, the company has made significant progress, prompting us to sit down with Stephanie von Staa Toledo, Oya’s Founder & CEO, to discuss her journey as she works to position Oya as…

Pozitivf Secures $20M in Funding to Democratize Fertility Treatment for All

San Antonio-based fertility clinic network Pozitivf has recently raised $20 million in a funding round led by MonCap. This investment, among the most significant in the fertility space, is aimed at expanding Pozitivf’s reach and making fertility treatments such as IVF more affordable across the United States. Pozitivf’s service model offers IVF procedures starting at a cost of $7,995, which is significantly…

UK-based Juniper Raises £1.5M to Launch Novel Reproductive Healthcare Insurance

Juniper, a London-based company, has secured £1.5 million in pre-seed funding to launch a novel reproductive healthcare insurance offering for employees. The funding round, led by Insurtech Gateway with contributions from 2100 Ventures, Exceptional Ventures, and Heartfelt, as well as several angel investors, is aimed at establishing Juniper’s presence in the insurance market, with a focus on supporting employees’ reproductive health needs.…

FHI 360 Initiates Phase I Clinical Trial for Biodegradable Contraceptive Implant

FHI 360 has commenced a pivotal Phase I clinical trial in the Dominican Republic for Casea S, a novel biodegradable contraceptive implant, marking the first trial of its kind in over two decades. Aimed at offering a long-term contraception solution, Casea S is engineered to release the synthetic hormone etonogestrel, commonly used in other contraceptive implants, to prevent pregnancy for a duration…

Proov Launches Comprehensive At-Home Fertility Program as Affordable IVF Alternative

Reproductive health company Proov has recently launched the Proov Path to Pregnancy, a new at-home fertility treatment program offering a less invasive and more affordable option compared to traditional in-vitro fertilization (IVF). Amy Beckley, CEO and Founder of Proov, was inspired to create this program based on her personal challenges with infertility, aiming to provide easier access to effective fertility solutions. “In…